As of Dec 15
| 0.00 / 0.00%|
The 23 analysts offering 12-month price forecasts for Jazz Pharmaceuticals PLC have a median target of 177.00, with a high estimate of 210.00 and a low estimate of 146.00. The median estimate represents a +30.60% increase from the last price of 135.53.
The current consensus among 23 polled investment analysts is to Buy stock in Jazz Pharmaceuticals PLC. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.